Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00514865 · ClinicalTrials.gov registry record · Phase 2
Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
A Phase 2 study, sponsored by Ono Pharma USA.
- Completed
- Registry status
- Phase 2
- Development phase
- 278
- Enrollment target
NCT00514865 is a Phase 2 study that has completed, run by Ono Pharma USA. The registered enrollment target is 278 participants.
The verdict
NCT00514865, a Phase 2 study, has completed, sponsored by Ono Pharma USA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 278 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of ONO-2333Ms in patients with Recurrent Major Depressive Disorder
Interventions
- DRUG Placebo
- DRUG ONO-2333Ms Experimental 2
- DRUG ONO-2333Ms Experimental 1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2007-06-13 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00514865
The ClinicalTrials.gov registry entry for NCT00514865 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 278 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ono Pharma USA, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00514865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00514865 about?
NCT00514865 is a clinical study titled "Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder". The purpose of this study is to evaluate the safety and efficacy of ONO-2333Ms in patients with Recurrent Major Depressive Disorder
What is the current status of trial NCT00514865?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 278 participants. The study started on 2007-06-13. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00514865?
The interventions under investigation include: Placebo (DRUG), ONO-2333Ms Experimental 2 (DRUG), ONO-2333Ms Experimental 1 (DRUG).
Who is sponsoring clinical trial NCT00514865?
This trial is sponsored by Ono Pharma USA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.